Prescient Therapeutics Revenue

Biotechnology Research • Level 11, 385 Bourke Street, Australia • 11-20 Employees

Prescient Therapeutics revenue & valuation

Annual revenue	$688,000
Revenue per employee	$46,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,300,000
Total funding	$3,000,000

Key Contacts at Prescient Therapeutics

Upaly Bahadure

Director Clinical Affairs And Operations

James Mcdonnell

Chief Executive Officer

Gavin Shepherd

Non Executive Director

Mariam Mansour

Senior Director – Clinical Development And Translational Sciences

Company overview

Headquarters	Level 11, 385 Bourke Street, Suite 2, Melbourne, Victoria 3205, AU
Phone number	+61390779233
Website	ptxtherapeutics.com
NAICS	541714
SIC	873
Founded	2014
Employees	11-20
Socials

Prescient Therapeutics Email Formats

Prescient Therapeutics uses 3 email formats. The most common is {first initial} (e.g., j@ptxtherapeutics.com), used 55.6% of the time.

Format	Example	Percentage
{first initial}	j@ptxtherapeutics.com	55.6%
{first initial}{last name}	jdoe@ptxtherapeutics.com	22.2%
{first name}	john@ptxtherapeutics.com	22.2%

About Prescient Therapeutics

Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies. Prescient’s technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Targeted therapy: Prescient’s first in class targeted therapy – PTX-100 – is currently in clinical development and showing encouraging activity in diseases of unmet need. Cell therapies: Prescient owns the exclusive rights to two next-generation cell therapy platform technologies, OmniCAR and CellPryme – both with the potential to enhance CAR-T therapies and overcome challenges faced by current generation approaches

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

C-Suite

Entry

Employees by Department

Prescient Therapeutics has 4 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Prescient Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2014-04-24	14	$3,000,000

Funding Insights

$3,000,000

Total funding amount

$3,000,000

Most recent funding amount

Number of funding rounds

Prescient Therapeutics Tech Stack

Discover the technologies and tools that power Prescient Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Vimeo

Video players

Hotjar

Analytics

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HubSpot Analytics

Analytics

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Frequently asked questions

Prescient Therapeutics is located in Level 11, 385 Bourke Street, AU.

You can reach Prescient Therapeutics at +61390779233.

Prescient Therapeutics generates an estimated annual revenue of $688,000. This revenue figure reflects the company's market position and business performance in its industry.

Prescient Therapeutics has an estimated valuation of $2,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Prescient Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

Prescient Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Prescient Therapeutics has raised a total of $3,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Prescient Therapeutics

Upaly Bahadure

Director Clinical Affairs And Operations

James Mcdonnell

Chief Executive Officer

Gavin Shepherd

Non Executive Director

Mariam Mansour

Senior Director – Clinical Development And Translational Sciences

4.8

40,000 users